New York, July 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Thrombosis And Hemostasis Biomarkers Market Size, Share & Industry Trends Analysis Report By ...

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented four abstracts at the Thrombosis and Hemostasis Summit of North ...

The global Hemostasis Diagnostics market, valued at approximately USD 6.41 billion in 2022, is projected to grow at a healthy CAGR of more than 8.60% during the forecast period from 2023 to 2030.

Clinical Phenotype: Can Each RBD be Characterized in Terms of Typical Bleeding Features? Patients affected by RBDs present with a wide range of clinical phenotypes – being asymptomatic at one end of ...

Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for ...

Women have specific health needs due to acquired hypercoagulable states which occur during different phases of life. For example, women may be at risk of thrombosis during pregnancy and the postpartum ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for side effects. Now new research by Fox Chase Cancer Center physicians shows ...

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5-Diagnostics (5-D), a worldwide distributor for haemostasis products and in-vitro diagnostics ...